Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08WTE
|
||||
Former ID |
DIB007488
|
||||
Drug Name |
Vorsetuzumab mafodotin
|
||||
Drug Type |
Antibody
|
||||
Indication | Renal cancer [ICD9: 140-229, 189; ICD10:C64] | Discontinued in Phase 1 | [547915] | ||
Company |
Seattle Genetics
|
||||
Target and Pathway | |||||
Target(s) | CD70 | Target Info | [550448] | ||
KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.